# Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) Patients

> **NCT00608127** · NA · UNKNOWN · sponsor: **Verto LTD** · enrollment: 10 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **DEVICE:** LupusorbTM

## Key facts

- **NCT ID:** NCT00608127
- **Lead sponsor:** Verto LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2008-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608127, "Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00608127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*